Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women
Editorial Group: Cochrane Gynaecological Cancer Group
Published Online: 14 JUL 2014
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Mosch CG, Jaschinski T, Eikermann M. Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011210. DOI: 10.1002/14651858.CD011210.
- Publication Status: New
- Published Online: 14 JUL 2014
This is the protocol for a review and there is no abstract. The objectives are as follows:
The purpose of this systematic review is to identify and summarise the results of randomised controlled trials that assess the benefits and harms of transvaginal sonography or other screening measures (e.g. serum CA-125 or HE4) and multimodal testing, for ovarian cancer screening in asymptomatic postmenopausal women with an average EOC risk by evaluating the screening-related patient-relevant outcomes (e.g. EOC-specific mortality rates).